Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Grossmann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Health Economics|July 31, 2013
Do cost-sharing and entry deregulation curb pharmaceutical innovation?Volker Grossmann
Plos One|January 11, 2021
The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent valueMario Songane, Volker Grossmann
Economics and Human Biology|December 1, 2023
The economics of aging with infectious and chronic diseasesHolger Strulik, Volker Grossmann
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Health Economics|July 31, 2013
Do cost-sharing and entry deregulation curb pharmaceutical innovation?Volker Grossmann
Plos One|January 11, 2021
The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent valueMario Songane, Volker Grossmann
Economics and Human Biology|December 1, 2023
The economics of aging with infectious and chronic diseasesHolger Strulik, Volker Grossmann
Pageof 1